Literature DB >> 18789374

A length polymorphism in the circadian clock gene Per3 influences age at onset of bipolar disorder.

Francesco Benedetti1, Sara Dallaspezia, Cristina Colombo, Adele Pirovano, Elena Marino, Enrico Smeraldi.   

Abstract

Age at onset of bipolar disorder might represent the penetrance of the system for specific genetic liability involved in the genesis of the illness. Genetic factors influencing age at onset have been shown to play a role in shaping core characteristics of the illness, such as severity and pattern of recurrence. Genetic variants of genes regulating the circadian clock could contribute to define endophenotypes of bipolar disorder, and have been associated with clinical features of the disease. The coding region of Per3 gene contains a variable-number tandem-repeat (VNTR) polymorphism which has been associated with diurnal preference, sleep structure and sleep homeostasis in healthy subjects. In a homogeneous sample of 99 patients affected by bipolar disorder type I we observed that Per3 VNTR influenced age at onset of illness: earlier age at onset in homozygote carriers of Per35 variant, later in homozygotes for Per34, and intermediate in heterozygotes. Allele frequencies were not significantly different from those reported in healthy subjects. Results need to be confirmed in larger samples, but warrant interest for the variants of molecular clock genes as possible endophenotypes of bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18789374     DOI: 10.1016/j.neulet.2008.09.002

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  59 in total

1.  Searching for genetic clues at the interface of sleep and mood.

Authors:  Namni Goel
Journal:  Sleep       Date:  2012-06-01       Impact factor: 5.849

2.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

Review 3.  Circadian rhythms and mood regulation: insights from pre-clinical models.

Authors:  Colleen A McClung
Journal:  Eur Neuropsychopharmacol       Date:  2011-08-11       Impact factor: 4.600

4.  Testing the role of circadian genes in conferring risk for psychiatric disorders.

Authors:  Enda M Byrne; Andrew C Heath; Pamela A F Madden; Michele L Pergadia; Ian B Hickie; Grant W Montgomery; Nicholas G Martin; Naomi R Wray
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-03-29       Impact factor: 3.568

Review 5.  Clock gene variants in mood and anxiety disorders.

Authors:  Timo Partonen
Journal:  J Neural Transm (Vienna)       Date:  2012-04-27       Impact factor: 3.575

Review 6.  Melatonin, circadian rhythms, and the clock genes in bipolar disorder.

Authors:  Sara Dallaspezia; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

7.  Chronotype and a PERIOD3 variable number tandem repeat polymorphism in Han Chinese pilots.

Authors:  Huaijie An; Zhiming Zhu; Changxi Zhou; Peiliang Geng; Hongtao Xu; Haiwei Wang; Ruxue Chen; Xiuhua Qu; Hairong Qian; Yuan Gao; Xiaohang Zhao; Yangming Qian
Journal:  Int J Clin Exp Med       Date:  2014-10-15

8.  Sleep and Circadian Rhythm Disorder in Bipolar Affective Disorder.

Authors:  Attia Ahmad; Kirstie N Anderson; Stuart Watson
Journal:  Curr Top Behav Neurosci       Date:  2021

9.  Melatonin suppression by melanopsin-weighted light in patients with bipolar I disorder compared to healthy controls

Authors:  Philipp Ritter; Falk Wieland; Debra J. Skene; Andrea Pfennig; Maria Weiss; Michael Bauer; Emanuel Severus; Henry Güldner; Cathrin Sauer; Bettina Soltmann; Stefanie Neumann
Journal:  J Psychiatry Neurosci       Date:  2020-03-01       Impact factor: 6.186

10.  Association of the Period3 clock gene length polymorphism with salivary cortisol secretion among police officers.

Authors:  Michael Wirth; James Burch; John Violanti; Cecil Burchfiel; Desta Fekedulegn; Michael Andrew; Hongmei Zhang; Diane B Miller; Shawn D Youngstedt; James R Hébert; John E Vena
Journal:  Neuro Endocrinol Lett       Date:  2013       Impact factor: 0.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.